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ABSTRACT
Context: There are numerous pharmacological activities for Ruta graveolens and its bioactive constituent,
rutin, on learning and memory.
Objective: This study aimed to examine the effect of R. graveolens and rutin on memory in rats.
Materials and methods: In this study animals were treated with the hydroalcholic extract of R. graveo-
lens and rutin by IP injection for 10days. Behavioural and biochemical tests as well as HPLC analysis and
antioxidant activity of extract have been evaluated.
Results: R. graveolens extract and rutin significantly increased learning and improved spatial memory, as
well as secondary latency; moreover, there were significant increases in the serum and brain antioxidant
capacity as well as the level of TBARS in serum and brain tissues. Results also showed that R. graveolens
has significant DPPH radical scavenging effect (IC50: 159.17±1.56lg/mL). The HPLC analysis of extract
showed that caffeic acid (19.92±0.01), rutin (40.15±0.01), and apigenin (0.84±0.01) mg/g of dry extract
are the main components of the extract.
Discussion and conclusion: Regarding the effects of R. graveolens extract and rutin on animal brain cells,
memory function, and learning, additional studies, including clinical trials, might be beneficial in produc-
ing natural supplementary drugs from this herb.
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Introduction
Learning and memory are the hallmarks of human beings.
Learning and memory are among the highest functional levels of
the central nervous system (CNS) (Spencer et al. 2009). Memory
is a biological adaptation that enables a living organism to use
past experiences to regulate its behaviour against environmental
changes. Memory is assumed to be the result of long-term
changes induced by learning in the relationship between neurons
(Holroyd and Shepherd 2001). The spatial memory and long-
term memory are constantly forming in the hippocampus (Diba
et al. 2018). Since learning and memory are important issues in
science and technology advancement and the number of people
with learning and memory disorders is increasing, using herbal
drugs in the treatment of forgetfulness and enhancing memory
has been a topic of interest for many researchers (Izadpanah
et al. 2017). These herbs have been used since ancient times and
they rarely lead to side effects (Jamshidi-Kia et al. 2018). There
are many medicinal herbs effective in enhancing memory and
learning. Ruta graveolens L. (Rutaceae), which has significant
therapeutic properties, is one of the medicinal herbs used in
traditional medicine in Iran and some other countries (Shojaii
et al. 2016). This herb is referred to as panacea due to its high
therapeutic value include the treatment of anticular, ear, phar-
ynx, neurological, pulmonary, digestive, renal, gynecological dis-
eases, parasites excretion, pain relief, and treatment of spasm
and inflammation (Asgarpanah and Khoshkam 2012; Ratheesh
et al. 2013; Baharvand-Ahmadi et al. 2015; Javadi and Emami
2015). There are more than 120 compounds of different types of
flavonoid glycosides, quinoline alkaloids, coumarins, lignins, and
flavonoids as the active ingredients of R. graveolens (Stashenko
et al. 2000; Gentile et al. 2015). Among these flavonoids, rutin
has been a topic of interest for researchers (Adsersen et al.
2006). Also, as a major compound of R. graveolens, rutin enhan-
ces memory retrieval and has pharmacological activities, includ-
ing anti-allergic, anti-inflammatory, anticancer, antiviral, and
antimycotic properties (Jianxiong et al. 2008). Therefore, the pre-
sent study was conducted to investigate and compare the effect
of hydroalcholic extract of R. graveolens and rutin on spatial
memory and passive avoidance memory in rats.
Materials and methods
Extraction
Fresh R. graveolens was purchased from local market on April
2016. Moreover, after identifying the herb by an expert botanist
(Shirmardi, Hamzeh Ali, PhD., Research Centre of Agriculture
and Natural Resources, P.O. Box 415, Shahrekord, Iran); it was
deposited to the Herbarium Unit of Shahrekord University of
Medical Sciences (Herbarium No. 152). To extract the dried and
pulverized sample, ethanol 70% was used. The obtained extract
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was filtered and concentrated in a rotary vacuum evaporator
after 72 h. Furthermore, the concentrated extract was incubated
at 37 C for final drying (Pandey et al. 2012).
Determining the antioxidant capacity of the extract
After preparation and incubation of the extract stock solution
and DPPH (diphenyl picryl hydrazine) at room temperature and
in the dark for 15min, the absorbance of the samples was
recorded at 517 nm wavelength. Methanol was used as blank and
methanol and DPPH were used as control. By measuring the
quantity of free radicals inhibited by the extract, the antioxidant
activity was reported to be IC50 (Ghasemi et al. 2009).
Determination of total phenolic and flavonoid content
Total phenolic and flavonoid content of the extract was deter-
mined using Folin-Ciocalteu reagent and the aluminium chloride
colorimetric method, respectively. To achieve this purpose, total
phenolic and flavonoid content was calculated by the calibration
curve, and the results were expressed as mg gallic acid equivalent
(GAE) and rutin equivalent/g of the extract dry weight, respect-
ively (Medini et al. 2014).
Standardisation and analysis of flavonoid and phenolic
compounds by HPLC
HPLC was used for qualitative analysis of the phenolic acid and
flavonoids (Knauer, Germany). The system was equipped with a
C18 column (5mm particle size, i.d. 250mm  4.6mm) and
UV–visible detector (PDA Detector 2800). The binary mobile
phase, including solvent A (methanol and 0.05% trifluoroacetic
acid) and solvent B (deionized water and 0.05% trifluoroacetic
acid) was eluted as follows to wash and equilibrate the column:
0–10min, 20% solvent A and 80% solvent B; 10–40min, 30%
solvent A and 70% solvent B; 40–45min, 60% solvent A and
40% solvent B; 45–50min, 80% solvent A and 20% solvent B;
and 50–55min, 100% solvent A and 0% solvent B. The flow rate
was 0.5mL/min and the injection volume was 20 mL. Detection
was performed by scanning at 190–800 nm wavelength and read-
ing the absorbance at 280–372 nm wavelength. Phenolic acid and
flavonoids were identified by comparing their UV spectra and
retention times to the analytical standards. Also, a calibration
curve equation was used to calculate the content of each flavon-
oid and phenolic acid, and the results were expressed as mg/mg
of the extract dry weight.
Laboratory animals
The study protocol was designed according to the ‘Guide for the
Care and Use of Laboratory Animals’, approved by the Research
Ethics Committee of Shahrekord University of Medical Sciences
(IR.SKUMS.REC.1394.241). 40 male Wistar rats weighing
250–300 g were purchased for this study from Pasteur Institution
(Tehran, Iran). Rats were kept at the temperature of 21 ± 2 C,
under 12 h light/dark cycle with free access to similar food and
water. The rats were assigned to 8 groups (n¼ 5), including
group 1: receiving normal saline (1mg/kg), groups 2, 3, and 4:
intraperitoneally receiving R. graveolens extract with concentra-
tions of 30, 100 and 300mg/kg, respectively (Sailani and Moeini
2007), and group 5: receiving rutin (10mg/kg) (Nassiri-Asl
et al. 2010).
Morris water maze test
Each rat was given 60min to find the platform in Morris water
maze test. If a rat could not find the platform, it was guided to
the platform. The rats were allowed to rest for 30 s between each
two trials to explore the environment. Also, rats were taken out
from water for 10min between two blocks, and those were
allowed to rest in the cage. Each rat was trained 4 times per day
for 4 days, and the test was repeated without the platform on day
5 (probe day) (Tarnawski et al. 2006).
Shuttle box test
The shuttle box test lasted 4 days for each rat. During the first
and second days, each rat was left in the box to acclimatize to it.
Moreover, an acquisition test was conducted on day 3. The rats
were separately placed in the bright chamber of the shuttle box
for this purpose. After a 2min acclimatisation period, guillotine
door was opened and after the rat got into the dark chamber, it
was closed, and then an electrical shock (1mA, for a second)
was exerted to the rat, such that it only paddled. In this test, the
length of primary latency in entering the dark chamber on the
day 3 and the length of latency during passing on the day 4 were
recorded (Rabiei et al. 2014).
Measuring serum and the brain antioxidant capacity
Three solutions were used in order to measure serum and brain
antioxidant capacity: 1. Buffer (1.55mL sodium acetate, 8mL
concentrated acetic acid reaching 500mL by adding distilled
water), 2. Ferrous chloride solution (270mg FeCl3 (6H2O)
increased to 50mL by adding distilled water), and 3. Triazine
solution (47mg triazine dissolved in 40mL of 40mM HCl). The
working solution was prepared by adding 10mL of the first solu-
tion to 1mL of the second solution and 1mL of the third solu-
tion. Furthermore, 25 mL of the serum sample and 25 mL of the
homogenized brain sample were added to 1.5mL of the working
solution and stored at 37 C. Optical absorbance was measured
at 593 nm (Benzie and Strain 1999).
Measuring serum and brain MDA levels
To measure the serum MDA level, 0.5 g of thiobarbituric acid
was mixed with 80mL of 20% acetic acid and then, the PH was
adjusted to 3.5 using NaOH and its volume was increased to
100mL by adding 20% acetic acid. Also, 100 mL of the serum
sample was mixed with 100mL of 8.1% SDS and 2.5mL of the
working solution. The samples were left in a bain-marie for
60min and cooled, and then centrifuged at 4000 rpm. The
optical absorbance of the supernatant was recorded at 523 nm
wavelength. In order to measure the brain MDA level, 1 g of the
brain tissue was dissolved in cooled 2.5% KCL and the resulting
solution was homogenized at 10% w/v ratio, and then it was
incubated at 37 ± 1 C for 60min in a metabolic shaker. Then,
1mL of 5% tetrachloroacetic acid and 1mL of 67% thiobarbituric
acid were added to the solution and it was perfectly mixed after
each addition. The content of each vial was centrifuged at
2000 rpm for 15min. Then, the supernatant was transferred to
another tube and left in a bain-marie. 10min later, the tubes
were cooled and the optical absorbance was recorded at 535 nm
(Karatas et al. 2002).
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Statistical analysis
Data were analyzed in the GraphPad Prism software using one-
way ANOVA followed by Tukey’s post hoc test. The significance
level (p) was considered <0.05 in all calculations.
Results
Total phenolic and flavonoid contents and antioxidant
capacity of Ruta graveolens extract
The amounts of phenolic and flavonoid compounds in the R.
graveolens extract were 14.1 ± 0.47mg GAE/g of the dry extracts
and 15.8 ± 0.19mg rutin equivalent/g of the dry extract, respect-
ively. The obtained inhibitory activity of the R. graveolens extract
in DPPH radicals (IC50) was 159.17 ± 1.56lg/mL.
Standardisation and determination of flavonoids and
phenolic compounds by HPLC
The flavonoids and phenolic compounds, found in the herb
extract, were detected by comparing the inhibition time of the
samples’ peak levels with flavonoids and phenolic compounds
standards, and the amounts of the compounds were calculated
through calculating the sub-peak level. Five flavonoids (apigenin,
luteolin, naringenin, quercetin, and rutin) and one phenolic acid
(caffeic acid) were identified and their amounts were measured
by the lowest and highest inhibition time obtained for caffeic
acid and quercetin, respectively (Table 1).
The effect of Ruta graveolens extract and rutin on learning
and spatial memory in Morris Water Maze test
There were significant differences in two-way ANOVA between
different groups (p< 0.001). Bonferroni post hoc test showed
that, latency to find the platform on day 3 was significantly
lower in the groups receiving the extract with concentrations of
100 and 300mg/kg and the group treated with rutin (10mg/kg),
compared to the control group (p< 0.05, p< 0.01, p< 0.001,
respectively), but there was no significant difference between the
group receiving the extract with the concentration of 30mg/kg
and the control group (p> 0.05). There was also no significant
difference in latency between the groups receiving 100 and
300mg/kg of the extract and the group receiving rutin, but there
was a statistically significant difference between the group receiv-
ing the extract with concentration of 30mg/kg and the group
receiving rutin (p< 0.01). There was also a significant difference
between two of the extract groups (30 and 300mg/kg) (p< 0.05).
The latency in finding the platform on day 4 was significantly
lower in the groups receiving 100 and 300mg/kg of the extract
and the group treated with rutin (10mg/kg) compared to the
control (p< 0.001), but there was no significant difference
between the group receiving 30mg/kg of the extract and the con-
trol group (p> 0.05). There was also no significant difference in
latency between two of the extract (100 and 300mg/kg) groups
and the group receiving rutin, but there was a statistically signifi-
cant difference between the group receiving the extract with the
concentration of 30mg/kg and the group receiving rutin
(p< 0.001). There was also a significant difference between two
of the extract groups (30 and 300mg/kg) (p< 0.01).
The swimming duration in the target quadrant on the probe
day, was significantly higher in the group receiving 300mg/kg of
the extract and the group treated with rutin (10mg/kg) com-
pared to the control group (p< 0.01), but there was no signifi-
cant difference between the groups treated with 30 and 100mg/
kg of the extract and the control group (p> 0.05). There was
also no significant difference in the swimming duration between
two of the extract groups (100 and 300mg/kg) and the group
receiving rutin, but there was a statistically significant difference
between the other extract group (30mg/kg) and the group
receiving rutin (p< 0.05). There was also a significant difference
between two of the extract groups (30 and 300mg/kg) (p< 0.05)
(Figure 1).
The effect of Ruta graveolens extract and rutin on
avoidance memory in shuttle box test
There were significant differences between different groups in
one-way ANOVA (p< 0.001). Tukey’s post hoc test showed that
secondary latency was significantly increased in the groups
treated with 300mg/kg of the extract and rutin (10mg/kg) com-
pared to the control group (p< 0.05), but this increase was not
statistically significant in the groups treated with 30 and 100mg/
kg of the extract (p> 0.05). Also, there was no significant differ-
ence in secondary latency between the groups receiving the
extract (30, 100, and 300mg/kg) and the group receiving rutin
(p> 0.05). There was also no significant difference between the
groups receiving the extract (30, 100, and 300mg/kg) (p< 0.05)
(Figure 2).
The effect of Ruta graveolens extract and rutin on serum
antioxidant capacity
There were significant differences between different groups in
one-way ANOVA (p< 0.001). Tukey’s post hoc test showed that
in the groups receiving 30, 100 and 300mg/kg of the extract and
the group receiving rutin (10mg/kg), serum antioxidant capacity
Table 1. Flavonoids and phenolic compounds (mg/g of dry extract).
Caffeic acid Rutin Quercetin Naringenin Luteolin Apigenin
19.92 ± 0.01 40.15 ± 0.01 ND ND ND 0.84 ± 0.01
ND: Non-detectable.
Figure 1. Effect of intraperitoneal injection of Ruta graveolens L. extract and rutin
on latency to find the platform on day 3, 4 and duration of swimming in
the tank ring target quadrant; RG30, RG100 and RG300: groups treated with
30, 100 and 300mg/kg of R. graveolens extract; #, ##, ### significant difference
between control group and other groups (p< 0.05, p< 0.01, and p< 0.001),significant difference between rutin group and extract (p< 0.01) on day 3.
###significant difference between control group and other groups (p < 0.001),significant difference between rutin group and extract (p < 0.001) on day 4.
##significant difference between control group and other groups (p< 0.01),significant difference between rutin group and extract (p< 0.05) on probe day.
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was significantly increased, compared to the control group
(p< 0.001). According to the serum antioxidant capacity, there
was no significant difference between one of the groups receiving
extract (300mg/kg) and the group receiving rutin (p> 0.05), but
the difference between two of the groups receiving extract (30
and 100mg/kg) and rutin-receiving group was significant
(p< 0.001). There was also a significant difference between the
groups receiving extract (30, 100, and 300mg/kg) (p< 0.001)
(Figure 3).
The effect of Ruta graveolens extract and rutin on brain
antioxidant capacity
There were significant differences between different groups in
one-way ANOVA (p< 0.001). Tukey’s post hoc test showed that
the brain antioxidant capacity was significantly higher in the
groups receiving Ruta graveolens extract with the concentrations
of 30, 100, and 300mg/kg and the group receiving 10mg/kg
rutin, compared to the control group (p< 0.05, p< 0.01, and
p< 0.001, respectively). Regarding the brain antioxidant capacity,
there was no significant difference between two of the groups
receiving extract (100 and 300mg/kg) and the group receiving
rutin (p> 0.05), but the difference between one of the groups
receiving extract (30mg/kg) and the group receiving rutin was
significant (p< 0.05). There was also a significant difference
between two of the groups receiving extract (30 and 300mg/kg)
(p< 0.05) (Figure 4).
The effect of Ruta graveolens extract and rutin on serum
MDA level
There were significant differences between different groups in
one-way ANOVA (p< 0.001). Tukey’s post hoc test showed that
serum MDA level was significantly lower in the groups receiving
R. graveolens extract with the concentrations of 30, 100, and
300mg/kg and the group receiving rutin (10mg/kg), compared
to the control group (p< 0.001). There was no significant differ-
ence in serum MDA level between two of the groups receiving
extract (100 and 300mg/kg) and the group receiving rutin
(p> 0.05), but the difference between one of the groups receiving
extract (30mg/kg) and the group receiving rutin was significant
(p< 0.05). There was also a significant difference between two of
the groups receiving extract (30 and 300mg/kg) (p< 0.05)
(Figure 5).
The effect of Ruta graveolens extract and rutin on brain
MDA level
There were significant differences between different groups in
one-way ANOVA (p< 0.001). Tukey’s post test showed that the
brain MDA level was significantly decreased in the groups
receiving R. graveolens extract with the concentrations of 30, 100,
and 300mg/kg and the group treated with rutin (10mg/kg),
Figure 2. Effect of intraperitoneal injection of Ruta graveolens L. extract and rutin
on passive avoidance memory; RG30, RG100 and RG300: groups treated with
30, 100 and 300mg/kg of R. graveolens extract; # significant difference between
control group and other groups (p< 0.05).
Figure 3. Effect of intraperitoneal injection of Ruta graveolens L. extract and rutin
on serum antioxidant capacity; RG30, RG100 and RG300: groups treated with 30,
100 and 300mg/kg of R. graveolens extract; ### significant difference between
control group and other groups (p< 0.001),  significant difference between
rutin group and extract (p< 0.001).
Figure 4. Effect of intraperitoneal injection of Ruta graveolens L. extract and rutin
on brain antioxidant capacity; RG30, RG100 and RG300: groups treated with 30,
100 and 300mg/kg of R. graveolens extract; #, ##, ### significant difference
between control group and other groups (p< 0.05, p< 0.01, and p< 0.001),significant difference between rutin group and extract (p< 0.05).
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compared to the control group (p< 0.001). There was no signifi-
cant difference in brain MDA between the group receiving
300mg/kg of the extract and the group receiving rutin (p> 0.05),
but the difference between two of the groups receiving extract
(30 and 100mg/kg) and the group receiving rutin was significant
(p< 0.001). There were also significant differences between the
groups receiving extract (30 and 100mg/kg, 30 and 300mg/kg,
and 100 and 300mg/kg) (p< 0.05). The results of this test
showed that the effects of this extract were dose-dependent
(Figure 6).
Discussion
Poor memory, low memory retention, and slow recall are the
common problems in a world full of competition and stress.
Aging, stress, and emotions are some of the leading cause of
memory loss, forgetfulness, anxiety, high blood pressure, demen-
tia, or even more serious complications, such as Alzheimer and
schizophrenia. For centuries, natural compounds have been used
by human beings for their health and well-being. Recently,
demands for natural compounds and drugs have been increased
due to the numerous side effects and the cost of these synthetic
drugs used for treating disorders of the nervous system, learning,
and memory (Forouzanfar and Hosseinzadeh 2018; Safiaghdam
et al. 2018).
The group receiving 300mg/kg of the extract and the group
receiving rutin, compared to the control group, which this indi-
cates the improving effect of R. graveolens on the spatial mem-
ory. There was a significant difference between the doses 30 and
300mg/kg in comparing Morris water maze test results in the
groups receiving extract. There was also a significant difference
in the test results between one of the groups receiving extract
(30mg/kg) and the group receiving rutin. In addition, according
to the shuttle box test results, there was no significant difference
between different doses of extract and rutin. The results of the
current study indicated that total serum and brain antioxidant
capacity was significantly higher in the groups receiving 30, 100,
and 300mg/kg of the extract and the group receiving rutin, com-
pared to the control group. There were also significant differen-
ces in serum antioxidant capacity between the groups receiving
extract (30, 100 and 300mg/kg), and there was another one in
brain antioxidant capacity between two of the groups receiving
extract (30 and 300mg/kg). There were also significant differen-
ces in serum antioxidant capacity between two of the groups
receiving extract (30 and 300mg/kg) and the group receiving
rutin, and there was another one in brain antioxidant capacity
between one of the groups receiving extract (30mg/kg) and the
group receiving rutin. In addition, serum and brain MDA levels
were significantly decreased in the groups receiving 30, 100, and
300mg/kg of the R. graveolens extract and the group receiving
rutin, compared to the control group. There were also significant
differences in serum MDA level between two of the groups
receiving extract (30 and 300mg/kg) and another one in brain
MDA level between the groups receiving extract (30, 100, and
300mg/kg). There was also a statistically significant difference in
serum MDA level between one of the groups receiving extract
(30mg/kg) and the group receiving rutin, and there was another
significant difference in brain MDA level between two of the
groups receiving extract (30 and 100mg/kg) and the group
receiving rutin. In 2006, Adsersen et al. proved that the extract
of R. graveolens can inhibit acetylcholinesterase activity.
Therefore, this plant has been suggested to be effective in mem-
ory improvement (Adsersen et al. 2006). Talic et al. (2014) also
investigated the effect of R. graveolens on the inhibition of acetyl-
cholinesterase (AChE) and butyrylcholinesterase (BuChE), which
are considered as promising strategies in the treatment of
Alzheimer’s disease (AD). According to this study, the strongest
inhibition effect on AChE was detected within water extract of
rue (IC50 ¼ 50 mg/mL) and there was also a significant inhibition
effect on BuChE. These results are consistent with our results. In
a study conducted by Ratheesh et al. (2011) it was reported that
methanol extract of R. graveolens reduced the oxidative stress
and inflammation, and improved pathology induced in aorta of
hypercholesterolemic rats, such that the herb decreased the activ-
ities of cyclooxygenase-2 and myeloperoxidase, as well as the
concentration of thiobarbituric acid reactive substance, and
increased the antioxidant activities of certain enzymes such as
glutathione, indicating the antioxidant activity of the herb, which
this is in agreement with our study (Ratheesh et al. 2011).
Figure 5. Effect of intraperitoneal injection of Ruta graveolens L. extract and rutin
on serum malondialdehyde level; RG30, RG100 and RG300: groups treated with
30, 100 and 300mg/kg of R. graveolens extract; ###significant difference between
control group and other groups (p< 0.001), significant difference between rutin
group and extract (p< 0.05).
Figure 6. Effect of of Ruta graveolens L. extract and rutin on brain malondialde-
hyde level; RG30, RG100 and RG300: groups treated with 30, 100 and 300mg/kg
of R. graveolens extract; ###significant difference between control group and
other groups (p< 0.001), significant difference between rutin group and
extract (p< 0.001).
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Preethi et al. (2006) also reported that the low (homeopathic)
concentrations of R. graveolens had cytotoxic effects on human
lymphoma and fibroblastoma cells by controlling the oxygen free
radicals and preventing the peroxidation of membrane lipids,
and also saved the life of animals suffering from cancer (Preethi
et al. 2006). In the study of Abidin et al. (2004), implemented on
the relationship between oxidative stress and memory, stressful
periods and increased stress levels were associated with adverse
effect on memory and memory retention (Abidin et al. 2004).
Therefore, oxidative stress accelerates the aging process and
behaviours related to depression, dementia, and impairments of
memory and learning. MDA is a product of cell membrane lipids
peroxidation. Increasing the amounts of these lipid peroxides in
the nerve cells leads to cell damage. The body uses the antioxi-
dant system to cope with oxidative substances. In addition to
these systems, some medicinal herbs reduce the oxidative stress
and its adverse outcomes due to the antioxidants (Pandya et al.
2013; Rabiei et al. 2014).
The role of secondary metabolites in medicinal herbs, espe-
cially flavonoids, has been demonstrated in producing antioxi-
dant effects in treating diseases related to oxidative stress, such
as memory disorders and degenerative and inflammatory diseases
(Bahmani et al. 2015; Kazemi et al. 2018). Rutin is one of the
most important flavonoids, which is effective in memory impair-
ment through its antioxidative activity (Ramalingayya et al.
2017). R. graveolens is one of the medicinal herbs that has high
amounts of flavonoids, especially rutin, and phenolic acids, par-
ticularly caffeic acid. The current study separately evaluated and
confirmed the positive effects of rutin on memory and learning.
In a study by Raghav et al. (2006), implemented on the anti-
inflammatory effects of R. graveolens lavender extract on adipose
tissue macrophages, it was indicated that the herb has an active
flavonoid metabolite, which a large part of this flavonoid metab-
olite is consisted of rutin (Raghav et al. 2006).
In standardising the extract in the present study, the amounts
of rutin, apigenin, and caffeic acid were 40.15, 0.84, and
19.92 lg/mL of dry extract, respectively, using HPLC analysis. In
a study by Proestos et al. (2006), the amounts of phenolic and
flavonoid compounds were measured in aromatic plants, such as
R. graveolens, in which the amounts of caffeic acid, rutin, and
quercetin were 20.1, 40.1 and 3.1 lg/mL of dry extract, respect-
ively, and the amounts of apigenin, luteolin, and naringenin
were not adequate to be detected. Besides that, the antioxidant
capacity of the R. graveolens leaf was 159.17lg/mL in the DPPH
method (IC50), and the total phenolic content of the herb extract
was calculated at 14.1mg/g of dry extract.
These results indicate the presence of antioxidant substances
in the herb, most important of which are rutin and caffeic acid.
The investigations of Fernandes et al. (2014) showed that caffeic
acid could improve the memory loss in mice through cholinergic
mediators and by coping with oxidative stress.
The beneficial effects of this herb on memory and learning
are likely to be due to the presence of caffeic acid and its efficacy
is through this pathway. In addition, as the previous studies have
demonstrated the effect of rutin in reducing oxidative stress and
its optimal effects on memory (Habtemariam 2016), the results
of this part of our study confirms the presence of high amounts
of rutin in the herb. The properties of rutin observed in different
tests in our study seem to be due to its antioxidant properties
and the resulting decrease in inflammatory substances that dam-
age the neurons.
The inhibitory effects of rutin on GABA transaminase
(GABA-T) and succinate-semialdehyde dehydrogenase have been
indicated in numerous in-vitro studies. Inhibition of the two
enzymes in the brain tissue increases GABA levels and may have
therapeutic applications in neurological disorders. In addition,
GABA-T is known as an important target for some of the drugs
effective in the brain. Therefore, the inhibition of flavonoids by
these enzymes may lead to exhibiting neuro-pharmacological
effects (Tao et al. 2008). Therefore, it seems that improving
memory and learning in the group receiving rutin in our study
may also be due to increased amount of GABA.
In general, the memory-enhancing effects of the extract were
increased by increasing the dose of the R. graveolens extract, so
that the memory-enhancing-effect of the 300mg/kg of the extract
and rutin is stronger than 30 and 100mg/kg of the extract. By
comparing the results of total extract and the pure substance of
rutin as the main substance of this plant, it can be concluded
that rutin is sufficiently potent in comparison to the 30 and
100mg/kg of the extract. In most tests, the extract had relatively
similar strength to rutin (10mg/kg) only at 300mg/kg.
According to the results of the HPLC analysis, it seems that
about 249mg of the extract contains 10mg of rutin, which con-
firms the equivalent response of rutin to that of the extract at
the dose of 300mg/kg. However, the effect of the extract at this
dose can also be attributed to a phenolic acid, namely, caffeic
acid, in addition to its main compound rutin.
Conclusion
The results of this study showed that intraperitoneal injection of
hydroalcholic extract of R. graveolens and rutin, due to their
potent antioxidant activities, increased serum and brain antioxi-
dant capacity and decreased serum and brain MDA levels. This
herb is likely to enhance memory and learning performance
through these mechanisms. It is therefore suggested that after
additional studies on animal samples and human subjects, the
herb can be used as a supplement in preventing and reducing
the adverse effects of oxidative stress, regarding the acceleration
of the aging process and behaviours associated with depression,
dementia, and memory and learning disorders.
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